171 related articles for article (PubMed ID: 8701702)
1. Short-course intravenous antibiotics with oral quinolone prophylaxis in the treatment of neutropenic fever in autologous bone marrow or peripheral blood progenitor cell transplant recipients.
Mahendra P; Jacobson SK; Ager S; Bass G; Barker P; Johnson D; Baglin TP; Marcus RE
Acta Haematol; 1996; 96(2):64-7. PubMed ID: 8701702
[TBL] [Abstract][Full Text] [Related]
2. Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
Gilbert C; Meisenberg B; Vredenburgh J; Ross M; Hussein A; Perfect J; Peters WP
J Clin Oncol; 1994 May; 12(5):1005-11. PubMed ID: 8164024
[TBL] [Abstract][Full Text] [Related]
3. Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option.
Seropian S; Nadkarni R; Jillella AP; Salloum E; Burtness B; Hu GL; Zelterman D; Cooper DL
Bone Marrow Transplant; 1999 Mar; 23(6):599-605. PubMed ID: 10217191
[TBL] [Abstract][Full Text] [Related]
4. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
5. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
Offidani M; Corvatta L; Olivieri A; Rupoli S; Frayfer J; Mele A; Manso E; Montanari M; Centurioni R; Leoni P
Bone Marrow Transplant; 1999 Nov; 24(10):1079-87. PubMed ID: 10578158
[TBL] [Abstract][Full Text] [Related]
6. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
Smith TJ; Hillner BE; Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Link H; Zander A; Yanovich S; Kitchin R; Erder MH
J Clin Oncol; 1997 Jan; 15(1):5-10. PubMed ID: 8996118
[TBL] [Abstract][Full Text] [Related]
7. Oral fluconazole for empiric treatment of prolonged Fever in neutropenic patients: prospective study in 250 consecutive patients after stem cell transplantation.
Stemmer SM; Maor Y; Hardan I
Am J Clin Oncol; 2004 Aug; 27(4):328-32. PubMed ID: 15289723
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
Eleutherakis-Papaiakovou E; Kostis E; Migkou M; Christoulas D; Terpos E; Gavriatopoulou M; Roussou M; Bournakis E; Kastritis E; Efstathiou E; Dimopoulos MA; Papadimitriou CA
Am J Hematol; 2010 Nov; 85(11):863-7. PubMed ID: 20882526
[TBL] [Abstract][Full Text] [Related]
9. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
Hess U; Böhme C; Rey K; Senn HJ
Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
[TBL] [Abstract][Full Text] [Related]
10. Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma.
Herrmann RP; Trent M; Cooney J; Cannell PK
Bone Marrow Transplant; 1999 Dec; 24(11):1213-7. PubMed ID: 10642811
[TBL] [Abstract][Full Text] [Related]
11. Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.
Antabli BA; Bross P; Siegel RS; Small CD; Tabbara IA
Int J Antimicrob Agents; 1999 Oct; 13(2):127-30. PubMed ID: 10595571
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
Koya R; Andersen J; Fernandez H; Goodman M; Spector N; Smith R; Hanlon J; Cassileth PA
Bone Marrow Transplant; 1998 May; 21(9):923-6. PubMed ID: 9613785
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation.
Egerer G; Goldschmidt H; Salwender H; Hegenbart U; Ehrhard I; Haas R; Ho AD
Int J Antimicrob Agents; 2000 Jul; 15(2):119-23. PubMed ID: 10854807
[TBL] [Abstract][Full Text] [Related]
14. Prolonged ciprofloxacin administration does not accelerate neutrophil recovery after autologous bone marrow transplantation.
Hsu J; Prince HM; Imrie KR
Pharmacotherapy; 1996; 16(4):652-5. PubMed ID: 8840372
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of hospitalized neutropenic oncology patients with Pseudomonas aeruginosa bloodstream infections: focus on oral fluoroquinolone conversion.
Yan LZ; Herrington JD
J Oncol Pharm Pract; 2016 Aug; 22(4):584-90. PubMed ID: 26156260
[TBL] [Abstract][Full Text] [Related]
16. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
[TBL] [Abstract][Full Text] [Related]
17. Penicillin or vancomycin plus ceftazidime in febrile neutropenic patients after stem cell transplantation.
Kargar Samani K; Vandercam B; Straetmans N; Michaux L; Ferrant A
Acta Clin Belg; 2000; 55(5):279-84. PubMed ID: 11109643
[TBL] [Abstract][Full Text] [Related]
18. Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation.
Larsson K; Björkstrand B; Ljungman P
Support Care Cancer; 1998 Jul; 6(4):378-83. PubMed ID: 9695206
[TBL] [Abstract][Full Text] [Related]
19. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
[TBL] [Abstract][Full Text] [Related]
20. Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation.
Egerer G; Goldschmidt H; Hensel M; Harter C; Schneeweiss A; Ehrhard I; Bastert G; Ho AD
Bone Marrow Transplant; 2002 Oct; 30(7):427-31. PubMed ID: 12368954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]